Jazz Pharmaceuticals

Nasdaq JAZZ · Dublin, Ireland

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Psychiatry · Renal & urogenital · Respiratory · Women's health

Jazz Pharmaceuticals is a clinical trial sponsor based in Dublin, Ireland, listed as Nasdaq JAZZ. It has 25 active clinical trials with 4,885 planned participants, across 15 therapeutic areas. Since 2021 it has completed 100 trials and stopped 31 early.

Trial track record · since 2021

25Active trials4,885 planned participants
100Completed86 with results posted
31Stopped early24% of finished trials

Financials · Nasdaq JAZZ

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 25 active trials

StageTrialStatus

On the market

8 approved drug applications with a product on the market.

Questions about Jazz Pharmaceuticals

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-08.

Approve Suite is not affiliated with Jazz Pharmaceuticals. Informational only.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.